Running big longevity experiments is crazy expensive. 1 study with 1,000 mice already cost hundreds thousands upfront, each mouse few hundred $ even before interventions start. Add gene therapy, labor, damage repair… the bill just go sky high. That’s why funding speed matter.

1/ The Nexus network continues to show its strength as a high-performance, verifiable computation layer. This report highlights key indicators of network health and why they matter for long-term growth. blog.nexus.xyz/nexus-network-…

The OFC Pre-TGE Portal is LIVE! 🚀 Link + How it works + New Information 👇

Aubrai is not just another AI agent. It exist to turn raw hypothesis → real market assets. The first Bioagent of Bio protocol eco With Bio Protocol , every idea validated can become IP-NFT → later fractionalized as IP-Tokens. That mean science is not lock in labs anymore, but

x.com/i/article/1966…

A biotech renaissance is emerging in the East. Fearless founders, regulatory agility, massive capital inflows. This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings. Here are some places we’ll be. RSVP links below. DM to meet.

Why Bioagents matter for science? Bioagents kinda change the way research move forward, because they fix a lot of broken things in old system. They make access more open, push innovation faster and also bring more clear transparency. Some points: 1. Open up funding & ownership

Back when Genesis launchpad first came out, my X feed was full of people talking about Virtuals Protocol and AI Agents. But as Virgen Points got inflated and lost value, I started seeing fewer mentions of Virtuals Protocol. Does that mean AI Agents aren’t hot anymore? I don’t think so.

Hôm nay vẫn chưa nhận được XP từ stake, chắc là hôm nay Bio Protocol trả XP từ yap nên mới khác mọi ngày

The next Ignition Sale is planned for next week. Another step in a long arc of experiments.

Pioneer Stone 🪨 Campaign is live on Galxe Quest Galxe. Before the gates open, prove you can hear the call. Early signals unlock early recognition. Start here → app.galxe.com/quest/FortePro…

A new round of yapping XP is now live in the Bio App 🔮 Check your XP: app.bio.xyz/bioxp This round covers August 25 to September 3. More XP distributions are coming and will occur before the next Ignition Sale. After this, BioXP will move to weekly distributions with

Aubrai-Redefining the future of longevity research Every groundbreaking idea starts with a question. With Aubrai , those questions don’t just inspire though-they fuel real scientific progress. Aubrai is more than an AI research co-pilot. It’s a living system that grows

Let’s take a closer look at what Aubrai is actually doing to help extend human lifespan 👇 Aubrai is one of the first big moves in Decentralized Science (DeSci). Built on Bio Protocol and working closely with groups like VitaDAO, it’s known as the world’s first “on-chain

Every day is the right day to get Bio Pilled

After going through “Highlights from last week in the Biosphere”, I came across a pretty interesting update. The team is pushing science forward step by step: 1. ~3x reduction in hallucinations for scientific cites → citations are far more reliable, giving researchers trust in

Mission SS5 on Somnia (100 Points) 👉 quest.somnia.network/campaigns/81 Take your Somnia-related PFP and turn it into pixel art. Deploy it as an NFT on Somnia Mainnet using nfts2me.com Limit minting to only 1 NFT per wallet. Share your artwork on X along with the

Forte Protocol Launches first Galxe Quest – Backed by $910M! Forte Protocol Forte Protocol is building the infrastructure layer for on chain economies. Helping projects launch, scale, and monetize with built-in tools for compliance, liquidity, and sustainable growth. Backed by

Most longevity research gets stuck in money problems and too much paperwork. Aubrai is doing it different, think of it like an AI scientist on-chain, throwing out hypotheses, testing, and sharing with everyone. The first mouse studies already showed longer lifespan, and now

In a quiet lab, two thousand mice become pioneers of a future where aging is no longer destiny. With RMR2, a bold $6M study designed not just to observe, but to test the very limits of biology. Unlike traditional research, this effort is not locked away. Aubrai the on-chain